Refine by
Oncology Services
108 services found
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
Innovative antibody-based molecular concepts. New treatments for cancer that leverage our own immune system to attack and destroy cancer cells can provide long-term and durable therapeutic responses in patients suffering from life-threatening malignancies. These benefits for patients have been driven by recently developed therapeutic antibodies binding with high specificity to drug targets on ...
by:veriNOS pharmaceuticals GmbH based inWuerzburg, GERMANY
Ronopterin – treatment to reduce peritumoral brain edema and improve patient outcomes. Adequate pharmacologic control of peritumoral edema in glioblastoma and brain metastases is still insufficient and is limited by side effects in more than 50% of the patients. ...
by:OracleBio based inGlasgow, UNITED KINGDOM
Adding value to Immuno-Oncology studies with Quantitative Digital Pathology. Quantitative Digital Pathology provides deep insights into the tumor microenvironment (TME), a knowledge which is crucial for understanding the mechanism of action of new oncology immunotherapies or for investigating new biomarkers. ...
by:Xeno Diagnostics, LLC based inIndianapolis, INDIANA (USA)
Xeno Diagnostics is a provider of in-vitro assays for early-stage drug development. We support biotech companies, pharmaceutical and academic life science organizations to enhance the quality and speed of their research. Our suite of assays and interaction with investigators have been designed to move the process forward. We are truly dedicated to making a difference for our ...
by:Oncimmune Holdings PLC based inNottingham, UNITED KINGDOM
Viewing cancer through the immune lens (immuno-oncology) has led to the most promising advancements in cancer treatment in recent history, nonetheless the full potential of the approach is as yet ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology is transforming drug discovery and development through our integrated scientific approach. Our expert team works to improve cancer outcomes each day for our research partners and ultimately patients across the ...
by:Jasper Health, Inc. based inBoise, IDAHO (USA)
A member-centric approach to remote patient monitoring that integrates with your systems and delivers outstanding engagement from your members and care team. Jasper Health can drive your oncology remote monitoring use cases with minimal integration and maximum efficiency. Our Care Team services are certified in psychosocial guidance and can augment your existing team. Our ...
Manufactured by:RareStone Group based inShanghai, CHINA
In recent years, the incidence of childhood cancer has been on the rise, and malignant tumor has become one of the main causes of death among adolescents. More than 250,000 children worldwide are diagnosed with cancer each year, and about 90,000 children die of cancer—making it the leading cause of death among children. In addition to leukemia, malignant lymphoma and other blood tumors, ...
by:Jasper Health, Inc. based inBoise, IDAHO (USA)
Built to be the first line of guidance when issues arise or symptoms deteriorate, helping avoid ER visits and acute in-hospital care escalations. Delivering on the promise of a value based oncology care ...
Manufactured by:MedGenome Inc. based inCounty of New Castle, DELAWARE (USA)
Profiling the Tumor Microenvironment: Using a genomics based approach to analyze the tumor microenvironment can provide unique insights beyond IHC and FACS methods. OncoPeptTUME deeply interrogates RNA-Seq data sets to produce high resolution mapping of the tumor microenvironment using proprietary cell type specific gene expression signatures. OncoPeptTUME provides a critical assessment of the ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology's ex vivo AML co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Acute Myeloid Leukemia (AML) researchers the ability to better understand their therapeutic mechanism of action. The Autologous AML Platform is an ex vivo co-culture assay developed and ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology's ex vivo 3D co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Immuno-Oncology researchers the ability to test their therapeutics in a 3D organoid assay that can mimic mechanism of action. The Autologous TIL platform is an ex vivo 3D ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Your Oncology Support Resource. At Natera, a test is more than just a test; it’s part of an integrated experience, built around a core suite of services to support patients and providers and to make testing ...
Manufactured by:Celyad Oncology based inMont-Saint-Guibert, BELGIUM
In-house production facility underpins broad CAR T pipeline. Over the past decade, Celyad Oncology has established expertise in Good Manufacturing Practice (GMP) grade cell therapy manufacturing at our 11,000 sq. ft. in-house facility, which is equipped to support our ongoing clinical trials. The manufacturing facility has been instrumental over the past few years in implementing ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Tumor-derived cell lines have long been used to discover the biologic processes in oncology, as well as screening platforms for discovering and evaluating the efficacy of anti-tumor therapeutics. ...
Manufactured by:Neovii Pharmaceuticals AG based inRapperswil, SWITZERLAND
We are looking to expand our portfolio of products with novel life-transforming therapies that address severe unmet medical needs in particular in the areas of transplantation, hemato-oncology, and immune ...
Manufactured by:Molecular Devices, LLC. based inSan Jose, CALIFORNIA (USA)
PDO end use applications include organ-on-a-chip, high throughput compound screening, 3D high content image analysis and applications in complex in-vitro assays for ...
by:Biocon based inElectronic City, INDIA
Bicara Therapeutics, a wholly owned subsidiary of Biocon based in Boston, U.S., is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology. Bicara enables access to the thriving innovation ecosystem in the U.S. which accelerates our development of cutting-edge therapies for cancer. Synergies between the scientific teams in Boston and ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Veracyte’s expertise in immuno-oncology and advanced data analytics delivers interpreted and actionable data using our proprietary platforms and technologies. ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
Including Pharmacokinetics and Immunogenicity. Designed to be an extension of your laboratory, Nexelis, a Q² Solutions Company, supports bioanalysis in all phases with agile assay development to validation mindset. Whether we design a custom bioanalytical assay or support a client’s technology transfer, our method development process results in an optimized assay compliant with global ...